GSK, Novartis, Sanofi Said To Be Bidding For $500 Million Elder Pharma
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline, Novartis and Sanofi are reported to be in various stages of bidding to buy Elder Pharmaceuticals, which could be worth $500 million.